Ameriprise Financial Inc. lifted its stake in Stryker Corporation (NYSE:SYK) by 3.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 787,925 shares of the medical technology company’s stock after acquiring an additional 26,305 shares during the period. Ameriprise Financial Inc. owned 0.21% of Stryker Corporation worth $109,367,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of SYK. BlackRock Inc. lifted its stake in shares of Stryker Corporation by 2,526.4% in the 1st quarter. BlackRock Inc. now owns 21,976,771 shares of the medical technology company’s stock worth $2,893,242,000 after acquiring an additional 21,140,000 shares during the period. Vanguard Group Inc. raised its holdings in shares of Stryker Corporation by 5.2% in the 1st quarter. Vanguard Group Inc. now owns 23,421,053 shares of the medical technology company’s stock worth $3,083,382,000 after purchasing an additional 1,161,688 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Stryker Corporation by 41.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,403,420 shares of the medical technology company’s stock worth $184,759,000 after purchasing an additional 414,715 shares in the last quarter. SG Americas Securities LLC raised its holdings in shares of Stryker Corporation by 600.6% in the 1st quarter. SG Americas Securities LLC now owns 412,340 shares of the medical technology company’s stock worth $54,285,000 after purchasing an additional 353,486 shares in the last quarter. Finally, Morgan Stanley raised its holdings in shares of Stryker Corporation by 17.9% in the 1st quarter. Morgan Stanley now owns 2,144,472 shares of the medical technology company’s stock worth $282,320,000 after purchasing an additional 325,661 shares in the last quarter. 74.13% of the stock is owned by institutional investors.

In other Stryker Corporation news, insider David Floyd sold 19,305 shares of Stryker Corporation stock in a transaction that occurred on Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total value of $2,790,730.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of Stryker Corporation stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the transaction, the insider now directly owns 8,983 shares in the company, valued at $1,313,853.58. The disclosure for this sale can be found here. In the last 90 days, insiders sold 25,429 shares of company stock valued at $3,686,927. 7.40% of the stock is owned by corporate insiders.

A number of analysts recently commented on the stock. Royal Bank Of Canada reiterated a “buy” rating and issued a $155.00 target price on shares of Stryker Corporation in a report on Monday, October 2nd. SunTrust Banks, Inc. restated a “buy” rating and set a $161.00 price target on shares of Stryker Corporation in a report on Monday, October 2nd. BidaskClub upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. Cowen and Company set a $160.00 price objective on shares of Stryker Corporation and gave the company a “buy” rating in a research note on Friday. Finally, Zacks Investment Research lowered shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $146.78.

ILLEGAL ACTIVITY WARNING: This article was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.thecerbatgem.com/2017/10/07/stryker-corporation-syk-shares-bought-by-ameriprise-financial-inc.html.

Stryker Corporation (SYK) opened at 149.00 on Friday. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $149.23. The company has a market capitalization of $55.74 billion, a PE ratio of 33.26 and a beta of 0.80. The firm’s 50-day moving average is $142.44 and its 200-day moving average is $139.99.

Stryker Corporation (NYSE:SYK) last issued its earnings results on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, topping the consensus estimate of $1.51 by $0.02. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The business had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.98 billion. During the same quarter last year, the company earned $1.39 EPS. The firm’s revenue was up 6.1% compared to the same quarter last year. On average, equities research analysts forecast that Stryker Corporation will post $6.46 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be paid a $0.425 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.70 annualized dividend and a yield of 1.14%. Stryker Corporation’s dividend payout ratio is currently 37.95%.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.